This inventor holds 60 USPTO granted patents and 15 published patent applications, plus 13 CIPO patents and 25 EPO patents, primarily in Polypeptide Production (CPC class C07K). Top assignees: Hoffmann-La Roche Inc., Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh. Active years: 1993-2026.
Inventors with similar research interests:
Location History:
- Tutzing, DE (1993)
- Deutschland, DE (2001)
- Penzberg, DE (1994 - 2024)
Company Filing History:
36 out of 5,016 
13 out of 1,164 
6 out of 487 
Years Active: 1993-2026
Areas of Expertise:
Title: Innovations and Contributions of Erhard Kopetzki
Introduction
Erhard Kopetzki is a notable inventor based in Penzberg, Germany, who has made significant contributions to the field of biotechnology. With a prolific record of 58 patents, he has pioneered advancements that aim to improve medical treatments and therapies, particularly in ophthalmology.
Latest Patents
Among his latest innovations, one remarkable patent is the "Rapid method for cloning and expression of cognate antibody variable gene segments." This method allows for the isolation of nucleic acid segments encoding antibody variable domains, enabling efficient insertion into eukaryotic expression plasmids without the need for clonal intermediate plasmid isolation and analysis.
Another significant patent focuses on "Fusion proteins for ophthalmology with increased eye retention." This invention combines a binding site that targets eye disease with another that enhances retention within the eye. It leverages the properties of collagen II found in the extracellular matrix of the vitreous humor, leading to improved drug delivery and retention for ocular therapies.
Career Highlights
Erhard Kopetzki has worked with prestigious organizations such as Hoffmann-La Roche Inc. and Boehringer Mannheim GmbH. His work at these companies has contributed to the development of cutting-edge biotechnology solutions that address complex medical challenges.
Collaborations
Kopetzki has collaborated with notable professionals in the field, including Yvo Graus and Paul Parren. These partnerships have fostered innovative research and the development of groundbreaking therapeutic technologies.
Conclusion
Erhard Kopetzki's extensive experience and innovative mindset have led to remarkable advancements in medical biotechnology. His patents not only reflect his ingenuity but also his commitment to improving patient care through scientific discovery. As the medical landscape continues to evolve, Kopetzki's contributions will remain integral to advancements in treatment and therapy.